K.N. Slaughter

Measurements of adiposity as clinical biomarkers for first-line bevacizumab-based chemotherapy in epithelial ovarian cancer

K.N. Slaughter, Theresa Thai, Shayla Penaroza et al. · Gynecologic Oncology · 2014 · 52 citations

First-line Bevacizumab-based Chemotherapy, Prognostic Biomarkers, Epithelial Ovarian Cancer +8

Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis

Kathleen N. Moore, James Java, K.N. Slaughter et al. · Gynecologic Oncology · 2016 · 49 citations · Full text

Advanced Cervical Cancer, Cervical Cancer, Cancer Detection +8

Geographic disparities in the distribution of the U.S. gynecologic oncology workforce: A Society of Gynecologic Oncology study

Stephanie Ricci, Ana I. Tergas, Kara Long Roche et al. · Gynecologic Oncology Reports · 2017 · 45 citations · Full text

Neuromuscular Organization of the Superior Longitudinalis Muscle in the Human Tongue

K.N. Slaughter, Haiyan Li, Alan J. Sokoloff · Cells Tissues Organs · 2005 · 44 citations

The survival detriment of venous thromboembolism with epithelial ovarian cancer

Camille C. Gunderson, Eric D. Thomas, K.N. Slaughter et al. · Gynecologic Oncology · 2014 · 36 citations

Thrombosis, Venous Disease, Venous Thrombosis +9